Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01BCQ
|
||||
Former ID |
DNC011384
|
||||
Drug Name |
Divaplon
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Terminated | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C17H17N3O2
|
||||
Canonical SMILES |
CCC1=C(N2C=C(N=C2N=C1OC)C(=O)C3=CC=CC=C3)C
|
||||
InChI |
1S/C17H17N3O2/c1-4-13-11(2)20-10-14(18-17(20)19-16(13)22-3)15(21)12-8-6-5-7-9-12/h5-10H,4H2,1-3H3
|
||||
InChIKey |
NRJVHCSYLGLURI-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 90808-12-1
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Gamma-aminobutyric acid receptor subunit alpha-1 | Target Info | Inhibitor | [2] | |
Gamma-aminobutyric acid receptor | Target Info | Inhibitor | [2] | ||
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
Retrograde endocannabinoid signaling | |||||
GABAergic synapse | |||||
Morphine addiction | |||||
Nicotine addiction | |||||
Reactome | Ligand-gated ion channel transport | ||||
GABA A receptor activation | |||||
WikiPathways | SIDS Susceptibility Pathways | ||||
Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | |||||
Iron uptake and transport | |||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000631) | ||||
REF 2 | J Med Chem. 1988 Jun;31(6):1220-6.(Imidazo[1,2-a]pyrimidin-2-yl)phenylmethanones and related compounds as potential nonsedative anxiolytics. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.